APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,695,033 | -46.7% | 71,180 | -58.2% | 0.41% | -41.8% |
| Q4 2022 | $8,808,954 | -0.5% | 170,353 | +31.5% | 0.70% | -6.3% |
| Q3 2022 | $8,850,000 | +0.3% | 129,577 | -33.6% | 0.75% | +0.5% |
| Q2 2022 | $8,824,000 | -21.5% | 195,126 | -11.8% | 0.75% | -15.3% |
| Q1 2022 | $11,242,000 | -43.9% | 221,251 | -47.8% | 0.88% | -31.0% |
| Q4 2021 | $20,031,000 | +194.0% | 423,676 | +104.9% | 1.28% | +202.4% |
| Q3 2021 | $6,814,000 | -72.7% | 206,746 | -47.7% | 0.42% | -66.6% |
| Q2 2021 | $24,966,000 | +53.4% | 395,033 | +4.1% | 1.27% | +17.2% |
| Q1 2021 | $16,280,000 | – | 379,395 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |